We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-0.39%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$579M
AUM Growth
+$10.3M
Cap. Flow
+$40.5M
Cap. Flow %
7%
Top 10 Hldgs %
80.36%
Holding
86
New
13
Increased
9
Reduced
4
Closed
5
Avg Time Held
2.8 years
Top 10 Avg Time Held
2.4 years
Top 20 Avg Time Held
2.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.59%
2 Industrials 23.83%
3 Healthcare 13.54%
4 Materials 5.99%
5 Technology 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RGTI icon
76
Rigetti Computing
RGTI
$4.22B
$21.1K ﹤0.01%
+1,500
New +$28.1K
2026 Q1
0 quarters
WGS icon
77
GeneDx Holdings
WGS
$2.09B
$19.5K ﹤0.01%
304
– –
2021 Q3
18 quarters
STRZ icon
78
Starz Entertainment Corp
STRZ
$434M
$12.6K ﹤0.01%
1,092
– –
2025 Q2
3 quarters
XFOR icon
79
X4 Pharmaceuticals
XFOR
$262M
$2.46K ﹤0.01%
595
– –
2019 Q4
25 quarters
AVNW icon
80
Aviat Networks
AVNW
$250M
$1.49K ﹤0.01%
66
– –
2020 Q2
23 quarters
SVREW icon
81
SaverOne 2014 Ltd Warrant
SVREW
$63.2K
$1.25K ﹤0.01%
121,000
– –
2022 Q2
15 quarters
AZ icon
82
A2Z Smart Technologies
AZ
$254M
– –
-62,000
Closed -$404K –
GPCR icon
83
Structure Therapeutics
GPCR
$1.58B
– –
-10,000
Closed -$696K –
LWLG icon
84
Lightwave Logic
LWLG
$648M
– –
-166,000
Closed -$538K –
PTN icon
85
Palatin Technologies
PTN
$11.6M
– –
-7,800
Closed -$120K –
SMTK
86
SmartKem
SMTK
$660K
– –
-932
Closed -$49.6K –

Similar funds

Bleichroeder LP's Q1 2026 Portfolio in Review

As of Q1 2026, Bleichroeder LP held 86 positions worth $579M, up 1.8% from $568M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Bleichroeder LP deployed $40.5M of net new capital in Q1 2026, opening 13 new positions and adding to 9 existing holdings. Its largest new stake was Envoy Medical: 6,250,000 shares worth $4.16M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 38% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Linde, an estimated $3.13M trimmed.

  • Bleichroeder LP's largest Q1 2026 buy was Envoy Medical: 6,250,000 shares worth $4.16M.
  • Bleichroeder LP added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $23.8M increase.
  • Bleichroeder LP's biggest Q1 2026 reduction was Linde, cutting an estimated $3.13M.
  • Bleichroeder LP fully exited Structure Therapeutics in Q1 2026, selling an estimated $696K.
  • Bleichroeder LP's ten largest holdings make up 80% of its $579M portfolio in Q1 2026.
  • Bleichroeder LP opened 13 new positions and closed 5 in Q1 2026.
  • Bleichroeder LP's portfolio value rose 1.8% quarter-over-quarter to $579M.

Based on Bleichroeder LP's 13F filing for Q1 2026, filed 14 May 2026.